TITLE

Amitriptyline vs Duloxetine for Diabetic Peripheral Neuropathic Pain

AUTHOR(S)
Kaur, H.
PUB. DATE
May 2011
SOURCE
Internal Medicine Alert;5/29/2011 Supplement, p80
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the double-blind crossover trial performed by H. Kaur and colleagues to compare the efficacy of amitriptyline with duloxetine in the treatment of diabetic peripheral neuropathic pain.
ACCESSION #
61180815

 

Related Articles

  • Amitriptyline vs Duloxetine for Diabetic Peripheral Neuropathic Pain.  // OB/GYN Clinical Alert;Jun2011 Clinical Brief, p12 

    The article discusses the double-blind crossover trial of amitriptyline and duloxetine in which these will be used as a treatment for diabetic peripheral neuropathic pain (DPNP).

  • Group Releases New Guideline on Options for Treating Painful Diabetic Neuropathy. Mitka, Mike // JAMA: Journal of the American Medical Association;6/22/2011, Vol. 305 Issue 24, p2507 

    The article focuses on the guideline released by the American Academy of Neurology in April 2011 for using effective therapies for patients with diabetic neuropathy. According to guideline author Vera Bril, the guideline was issued because of the availability of new treatments. It cites a study...

  • Controlling Diabetic Neuropathic Pain. Rubin, Michael // Internal Medicine Alert;11/29/2012, Vol. 34 Issue 22, p172 

    Three common medications -- amitripty-line, duloxetine, and pregabalin -- all appear equally efficacious in treating neuropathic pain from diabetic neuropathy.

  • Cost effectiveness of duloxetine painless in the US.  // PharmacoEconomics & Outcomes News;6/23/2012, Issue 656, p12 

    The article discusses a study on the cost-effectiveness of duloxetine versus pregabalin as treatment for painful diabetic neuropathy (PDN) by B.K. Bellows and colleagues, presented at the "17th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research."

  • Amitriptyline vs Duloxetine for Diabetic Peripheral Neuropathic Pain. Kuritzky, Louis // Infectious Disease Alert;Jun2011 Clinical Briefs in Primary, p12 

    The article discusses research by H. Kaur and colleagues which compared the efficiency of amitriptyline and duloxetine for diabetic peripheral neuropathic pain, published in a 2011 issue of "Diabetes Care."

  • Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia. Kinoshita, Jun; Yukari Takahashi; Watabe, Ayako M.; Utsunomiya, Kazunori; Fusao Kato // Molecular Pain;2013, Vol. 9 Issue 1, p1 

    Background Painful diabetic neuropathy (PDN) is a serious complication of diabetes mellitus that affects a large number of patients in many countries. The molecular mechanisms underlying the exaggerated nociception in PDN have not been established. Recently, duloxetine (DLX), a serotonin and...

  • Duloxetine.  // Reactions Weekly;8/8/2009, Issue 1264, p16 

    The article describes the case of a 61-year-old woman who developed hypomania while being treated with duloxetine. The patient had a history of recurrent depression and psychosis. She was treated with amitriptyline, mirtazapine, perphenazine, trifluoperazine and risperidone. She also was...

  • A Comparative Evaluation of Amitriptyline and Duloxetine in Painful Diabetic Neuropathy. KAUR, HARJOT; HOTA, DEBASISH; BHANSALI, ANIL; DUTTA, PINAKI; BANSAL, DIPIKA; CHAKRABARTI, AMITAVA // Diabetes Care;Apr2011, Vol. 34 Issue 4, p818 

    OBJECTIVE--To compare the efficacy and safety of duloxetine and amitriptyline in painful diabetic neuropathy (PDN). RESEARCH DESIGN AND METHODS--In this randomized, double-blind, cross-over, active-control trial, 58 patients received amitriptyline and duloxetine orally once daily at bed-time,...

  • Magnets could be useful option for neuropathic pain relief.  // Geriatrics;Mar99, Vol. 54 Issue 3, p23 

    Presents information on the study which determined the efficacy of magnet in reducing pain, numbness, and tingling sensation in patients with diabetic polyneuropathy. How the placebo response of the patients were stimulated; Findings of the study; Comments from Michael I. Weintraub, author of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics